The third quarter financial results of Usana Health Sciences (NYSE: USNA) will be unveiled on Tuesday 22nd October 2024. This eagerly awaited announcement is scheduled to occur after market close.
In accordance with the predictions of financial analysts on Wall Street, the firm is on track to report an expected per share of $0.48 profit for the quarter. Furthermore, the firm is projected to disclose a total revenue of $205.77 million for this quarter.
The forecasts for the company's annual performance have been disclosed by Wall Street analysts, with an estimated total revenue of $861.94 million. In addition, they anticipate the company to report profit of $2.49 per share for the fiscal year.
The company's earnings report for the same quarter in the previous year revealed a per-share income of $0.59, attributed to the company's total revenue of $213.37 million.
| Period | EPS Actual |
EPS Growth* |
Revenue Actual |
Revenue Growth* |
|---|---|---|---|---|
| Historical Earnings Insight | ||||
| Q2 2024 | $0.54 | -39.3% | 212.87 M | -10.6% |
| Q1 2024 | $0.86 | -9.5% | 227.80 M | -8.3% |
| Q4 2023 | $0.87 | +31.8% | 221.08 M | -3.0% |
| Q3 2023 | $0.59 | -24.4% | 213.37 M | -8.5% |
| Q2 2023 | $0.89 | -11.0% | 238.20 M | -9.9% |
| *Growth on year-over-year basis | ||||
In addition, The firm will review the third quarter financial results on 23rd October 2024 at 11:00 AM eastern time, in a conference call with public.
Usana Health Sciences (USNA) shares experienced a range of $35.78 to $36.35 on a day volume of 49.20 thousand shares. The stock closed Friday's regular trading session at $35.85, indicating a 1.05 percent decrease.
